Prostate-specific antigen in the cerebrospinal fluid leads to diagnosis of solitary cauda equina metastasis: a unique case report and review of the literature
1998

Prostate Cancer Metastasis Detected by PSA in Cerebrospinal Fluid

Sample size: 1 publication Evidence: low

Author Information

Author(s): B Schaller, A Merlol, E Kirsch, K Lehmann, PR Huber, P Lyrer, AJ Steck, O Gratzl

Primary Institution: University Hospitals, Basle, Switzerland

Hypothesis

Can elevated prostate-specific antigen (PSA) levels in cerebrospinal fluid help diagnose intradural prostate cancer metastasis?

Conclusion

PSA in the cerebrospinal fluid is a useful diagnostic tool for detecting intradural prostate cancer metastasis.

Supporting Evidence

  • PSA levels in the cerebrospinal fluid were significantly elevated at 29.1 ng/ml.
  • Normal serum PSA levels were found in the range of 2.4-5.1 ng/ml.
  • Histological examination confirmed poorly differentiated prostate carcinoma.

Takeaway

A 79-year-old man had prostate cancer that spread to his spine, but doctors only figured it out when they found high PSA levels in his spinal fluid, even though his blood tests were normal.

Methodology

The study involved a case report of a patient with prostate cancer and elevated PSA levels in cerebrospinal fluid, along with imaging and surgical confirmation.

Limitations

The diagnosis of intradural metastasis can be difficult and often delayed, even with advanced imaging techniques.

Participant Demographics

79-year-old male patient with a history of prostate cancer.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication